Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes

被引:41
作者
Espasa, M
González-Martín, J
Alcaide, F
Aragón, LM
Lonca, J
Manterola, JM
Salvadó, M
Tudó, G
Orús, P
Coll, P
机构
[1] Hosp Clin IDIBAPS, Ctr Diagnost Biomed, Dept Microbiol, Barcelona, Spain
[2] Hosp Univ Bellvitge, Microbiol Serv, Barcelona, Spain
[3] Hosp Univ Santa Creu & St Pau, Microbiol Serv, Barcelona, Spain
[4] Hosp Badalona Germans Trias & Pujol, Microbiol Serv, Barcelona, Spain
[5] Lab Referencia Catalunya, Microbiol Serv, Barcelona, Spain
关键词
TB; drug resistance; detection method;
D O I
10.1093/jac/dki132
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background. This study evaluates a method based on real-time PCR for direct detection in clinical samples of the common mutations responsible for isoniazid and rifampicin resistance of Mycobacterium tuberculosis. Methods: Six pairs of fluorogenic 5' exonuclease probes (Taqman (R)), mutated and wild-type, were designed for six targets: codon 315 of katG, substitution C209T in the regulatory region of inhA, and codons 513, 516, 526 and 531 of rpoB. Results: A total of 98 clinical samples harbouring resistant bacilli from 55 patients and 126 samples harbouring susceptible bacilli from 126 patients were processed. The isolates from samples were tested for drug susceptibility with the radiometric method and sequenced for the same genetic targets. Among the samples, 93 harboured isoniazid-resistant bacilli. According to the sequencing results, 30 had mutations in katG, 30 in inhA and 33 (35.4%) had no mutations in these targets. All 27 clinical specimens harbouring rifampicin-resistant bacilli showed mutations in rpoB. The detection threshold of this method in detecting target genes in serial dilutions of artificial samples was 1.5 x 10(3) cfu/mL. In clinical samples, the sensitivity ranged from 30.4 to 35.3% for smear-negative samples and from 95.1 to 99.2% for smear-positive samples, with a specificity of 100%. In this study, the overall sensitivity in detecting patients having the target mutations was 74.3%. Conclusions: The main advantage of the described method is the possibility of detecting rifampicin and isoniazid resistance within 48-72h after sample collection, with a sensitivity of nearly 100% in smear-positive samples if the chosen target is responsible for the resistance.
引用
收藏
页码:860 / 865
页数:6
相关论文
共 32 条
[1]  
[Anonymous], CLIN MICROBIOL INFEC
[2]   Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from new York City [J].
Cooksey, RC ;
Morlock, GP ;
Glickman, S ;
Crawford, JT .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (05) :1281-1283
[3]   Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons [J].
El-Hajj, HH ;
Marras, SAE ;
Tyagi, S ;
Kramer, FR ;
Alland, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) :4131-4137
[4]  
Escalante P., 1998, Tubercle and Lung Disease, V79, P111, DOI 10.1054/tuld.1998.0013
[5]   Global trends in resistance to antituberculosis drugs [J].
Espinal, MA ;
Laszlo, A ;
Simonsen, L ;
Boulahbal, F ;
Kim, SJ ;
Reniero, A ;
Hoffner, S ;
Rieder, HL ;
Binkin, N ;
Dye, C ;
Williams, R ;
Raviglione, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (17) :1294-1303
[6]   Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997) [J].
Fang, Z ;
Doig, C ;
Rayner, A ;
Kenna, DT ;
Watt, B ;
Forbes, KJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :998-1003
[7]   New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis [J].
Garcia de Viedma, D ;
Infantes, MDD ;
Lasala, F ;
Chaves, F ;
Alcalá, L ;
Bouza, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :988-995
[8]   Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates in Spain and their rapid detection by PCR-enzyme-linked immunosorbent assay [J].
Garcia, L ;
Alonso-Sanz, M ;
Rebollo, MJ ;
Tercero, JC ;
Chaves, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (05) :1813-1818
[9]   Simultaneous ide n-tification of Mycobacterium genus and Mycobacterium tuberculosis complex in clinical samples by 5′-exonuclease fluorogenic PCR [J].
García-Quintanilla, A ;
González-Martín, J ;
Tudó, G ;
Espasa, M ;
de Anta, MTJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (12) :4646-4651
[10]   Direct detection of multidrug-resistant mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay [J].
Johansen, IS ;
Lundgren, B ;
Sosnovskaja, A ;
Thomsen, VO .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (09) :4454-4456